I believe AB got the Jan 21 date as there was a statement allegedly made at the annual meeting by JF. I expect / hope for some sort of news from the FDA regarding vivagel soon, but this has been the case for months.. The FDA will work at their own pace unfortunately.
it's extremely frustrating, especially when you see the rest of the market performance recently.
hoping (the worst feeling for a share holder..) for some continued growth in vivagel sales in the RoW. The product is on the shelves in Australia, UK, Germany and I believe some other EU countries. Mundipharma also have regulatory approvals for a number of SEA countries so we should be seeing further market launches soon. Condom revenue in Japan I still believe will be a very small, but hopefully a nice high margin niche market for us.
buy short term for vivagel sales and stay for the dep technology!
2020 is our year, page-116
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.90M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.5¢ | 10.0¢ | $110.6K | 1.006M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 83046 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |